• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童医疗设备的非标签使用。

Off-Label Use of Medical Devices in Children.

出版信息

Pediatrics. 2017 Jan;139(1). doi: 10.1542/peds.2016-3439.

DOI:10.1542/peds.2016-3439
PMID:28025239
Abstract

Despite widespread therapeutic needs, the majority of medical and surgical devices used in children do not have approval or clearance from the Food and Drug Administration (FDA) for use in pediatric populations. The clinical need for devices to diagnose and treat diseases or conditions occurring in children has led to the widespread and necessary practice in pediatric medicine and surgery of using approved devices for "off-label" or "physician-directed" applications that are not included in FDA-approved labeling. This practice is common and often appropriate, even with the highest-risk (class III) devices. The legal and regulatory framework used by the FDA for devices is complex, and economic or market barriers to medical and surgical device development for children are significant. Given the need for pediatric medical and surgical devices and the challenges to pediatric device development, off-label use is a necessary and appropriate part of care. In addition, because of the relatively uncommon nature of pediatric conditions, FDA clearance or approval often requires other regulatory pathways (eg, Humanitarian Device Exemption), which can cause confusion among pediatricians and payers about whether a specific use, even of an approved device, is considered experimental. This policy statement describes the appropriateness of off-label use of devices in children; the use of devices approved or cleared through the FDA regulatory processes, including through the Humanitarian Device Exemption; and the important need to increase pediatric device labeling information for all devices and especially those that pose the highest risk to children.

摘要

尽管存在广泛的治疗需求,但用于儿童的大多数医疗和外科设备并未获得美国食品药品监督管理局(FDA)批准或认可用于儿科人群。对用于诊断和治疗儿童所患疾病或病症的设备的临床需求,导致在儿科医学和外科中广泛且必要地存在将已批准设备用于FDA批准标签中未包含的“标签外”或“医生指导”应用的做法。这种做法很常见,甚至对于风险最高的(III类)设备来说往往也是合适的。FDA用于设备的法律和监管框架很复杂,而且儿童医疗和外科设备开发面临重大的经济或市场障碍。鉴于对儿科医疗和外科设备的需求以及儿科设备开发面临的挑战,标签外使用是护理中必要且合适的一部分。此外,由于儿科病症相对不常见,FDA的批准或认可通常需要其他监管途径(例如,人道主义设备豁免),这可能会使儿科医生和支付方对特定用途(即使是已批准设备的用途)是否被视为试验性用途感到困惑。本政策声明描述了在儿童中标签外使用设备的适当性;通过FDA监管程序(包括通过人道主义设备豁免)批准或认可的设备的使用;以及增加所有设备尤其是对儿童构成最高风险的设备的儿科设备标签信息的重要必要性。

相似文献

1
Off-Label Use of Medical Devices in Children.儿童医疗设备的非标签使用。
Pediatrics. 2017 Jan;139(1). doi: 10.1542/peds.2016-3439.
2
Postmarketing trials and pediatric device approvals.上市后试验与儿科医疗器械批准
Pediatrics. 2014 May;133(5):e1197-202. doi: 10.1542/peds.2013-3348. Epub 2014 Apr 14.
3
Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications.高风险医疗器械有儿科适应证的美国食品和药物管理局上市前批准声明的定量评估。
JAMA Netw Open. 2021 Jun 1;4(6):e2112562. doi: 10.1001/jamanetworkopen.2021.12562.
4
Encouraging research and development of pediatric medical devices through legislative and regulatory action: the Pediatric Medical Device Safety and Improvement Act of 2007 in context.通过立法和监管行动鼓励儿科医疗设备的研发:2007年《儿科医疗设备安全与改进法案》背景介绍
Food Drug Law J. 2009;64(3):531-64.
5
Off-label use of medical products in radiation therapy: summary of the report of AAPM Task Group No. 121.医学产品在放射治疗中的标签外使用:AAPM 工作组第 121 号报告的总结。
Med Phys. 2010 May;37(5):2300-11. doi: 10.1118/1.3392286.
6
Pediatric Device Innovation: An Analysis of Food and Drug Administration Authorizations Over Time.儿科医疗器械创新:对食品和药物管理局授权的时间分析。
J Bone Joint Surg Am. 2024 Sep 4;106(17):1594-1599. doi: 10.2106/JBJS.23.01211. Epub 2024 Jun 5.
7
Off-label use of medical devices in radiology: regulatory standards and recent developments.医疗器械在放射科的超适应证使用:监管标准和最新进展。
J Am Coll Radiol. 2010;7(2):115-9. doi: 10.1016/j.jacr.2009.09.025.
8
Medical devices; pediatric uses of devices; requirement for submission of information on pediatric subpopulations that suffer from a disease or condition that a device is intended to treat, diagnose, or cure; direct final rule. Direct final rule.医疗器械;器械的儿科用途;提交有关患有器械旨在治疗、诊断或治愈的疾病或病症的儿科亚人群信息的要求;直接最终规则。直接最终规则。
Fed Regist. 2010 Apr 1;75(62):16347-51.
9
Medical devices; pediatric uses of devices; requirement for submission of information on pediatric subpopulations that suffer from a disease or condition that a device is intended to treat, diagnose, or cure. Final rule.医疗器械;器械的儿科用途;提交有关患有器械旨在治疗、诊断或治愈的疾病或病症的儿科亚群信息的要求。最终规则。
Fed Regist. 2014 Jan 10;79(7):1735-41.
10
Pediatric cardiac devices--an FDA pediatrician's perspective of the challenges and potential solutions.儿科心脏器械——FDA 儿科医生对挑战和潜在解决方案的看法。
J Cardiovasc Transl Res. 2009 Jun;2(2):147-9. doi: 10.1007/s12265-009-9100-2. Epub 2009 Mar 13.

引用本文的文献

1
Lack of children in public medical imaging data points to growing age bias in biomedical AI.公共医学影像数据中缺乏儿童数据,这表明生物医学人工智能中年龄偏见日益严重。
medRxiv. 2025 Jun 10:2025.06.06.25328913. doi: 10.1101/2025.06.06.25328913.
2
Artificial Placenta and Artificial Womb Technologies for Lung and Kidney Failure: A Holistic Perspective.用于肺和肾衰竭的人工胎盘和人工子宫技术:全面视角
ASAIO J. 2025 Apr 25. doi: 10.1097/MAT.0000000000002443.
3
Ethical considerations in AI for child health and recommendations for child-centered medical AI.
人工智能在儿童健康领域的伦理考量及以儿童为中心的医学人工智能建议。
NPJ Digit Med. 2025 Mar 10;8(1):152. doi: 10.1038/s41746-025-01541-1.
4
Bridging the Gap in FDA Approval for Pediatric Neuromodulation Devices.缩小美国食品药品监督管理局对儿科神经调节设备审批方面的差距。
Children (Basel). 2025 Jan 27;12(2):148. doi: 10.3390/children12020148.
5
Economic evaluations of medical devices in paediatrics: a systematic review and a quality appraisal of the literature.儿科医疗器械的经济评估:系统评价与文献质量评估
Cost Eff Resour Alloc. 2024 Apr 27;22(1):33. doi: 10.1186/s12962-024-00537-0.
6
Efficacy of human resource development program for young industry personnel who will be involved in future medical device development.未来医疗器械开发相关的年轻产业人员人力资源开发计划的效果。
Surg Endosc. 2023 Dec;37(12):9633-9642. doi: 10.1007/s00464-023-10474-3. Epub 2023 Oct 27.
7
US Food and Drug Administration Approval of High-risk Cardiovascular Devices for Use in Children and Adolescents, 1977-2021.美国食品和药物管理局批准高风险心血管设备用于儿童和青少年,1977-2021 年。
JAMA. 2022 Aug 9;328(6):580-582. doi: 10.1001/jama.2022.10041.
8
Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease.先天性心脏病的经导管器械治疗与先进成像技术的整合
Children (Basel). 2022 Apr 2;9(4):497. doi: 10.3390/children9040497.
9
The newborn delivery room of tomorrow: emerging and future technologies.未来的新生儿分娩室:新兴技术与未来技术。
Pediatr Res. 2024 Aug;96(3):586-594. doi: 10.1038/s41390-022-01988-y. Epub 2022 Mar 3.
10
Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications.高风险医疗器械有儿科适应证的美国食品和药物管理局上市前批准声明的定量评估。
JAMA Netw Open. 2021 Jun 1;4(6):e2112562. doi: 10.1001/jamanetworkopen.2021.12562.